U.S. Plasmid Purification Market (2025 - 2033) Size, Share & Trends Analysis Report By Product & Service (Instruments, Kits & Reagents), By Grade (Molecular Grade, Transfection Grade), By Application, By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Product & Service Segment
                        1.2.2. Grade Segment
                        1.2.3. Application Segment
                        1.2.4. End Use Segment
                    1.3. Information Analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data Validation & Publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
                        1.10.1. Objective 1
                        1.10.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. U.S. Plasmid Purification Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Vaccine development (especially DNA vaccines)
                            3.2.1.2. Rise in biopharmaceutical R&D
                        3.2.2. Market restraint analysis
                            3.2.2.1. Ethical constraints related to the use of rDNA technology
                            3.3. U.S. Plasmid Purification Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
Chapter 4. U.S. Plasmid Purification Market: Product & Service Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Plasmid Purification Market Product & Service Movement Analysis
                    4.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
                    4.4. Products
                        4.4.1. Products market estimates and forecasts, 2021 - 2033 (USD Million)
                        4.4.2. Instruments
                            4.4.2.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
                        4.4.3. Kits & Reagents
                            4.4.3.1. Kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
                    4.5. Services
                        4.5.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Plasmid Purification Market: Grade Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Plasmid Purification Market Grade Movement Analysis
                    5.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Grade, 2021 to 2033 (USD Million)
                    5.4. Molecular Grade
                        5.4.1. Molecular-grade market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.5. Transfection Grade
                        5.5.1. Transfection grade market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Plasmid Purification Market: Application Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Plasmid Purification Market Application Movement Analysis
                    6.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    6.4. Cloning & Protein Expression
                        6.4.1. Cloning & protein expression market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.5. Transfection & Gene Editing
                        6.5.1. Transfection & gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.6. Others
                        6.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Plasmid Purification Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Plasmid Purification Market End Use Movement Analysis
                    7.3. U.S. Plasmid Purification Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    7.4. Pharmaceutical & Biotechnology Companies
                        7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
                    7.5. Academic & Research Institutes
                        7.5.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
                    7.6. Contract Research Organizations
                        7.6.1. Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company/Competition Categorization
                    8.2. Strategy Mapping
                    8.3. Company Market Position Analysis, 2024
                    8.4. Company Profiles/Listing
                        8.4.1. Merck KGaA
                            8.4.1.1. Company overview
                            8.4.1.2. Financial performance
                            8.4.1.3. Product/Service benchmarking
                            8.4.1.4. Strategic initiatives
                        8.4.2. QIAGEN
                            8.4.2.1. Company overview
                            8.4.2.2. Financial performance
                            8.4.2.3. Product/Service benchmarking
                            8.4.2.4. Strategic initiatives
                        8.4.3. Thermo Fisher Scientific, Inc.
                            8.4.3.1. Company overview
                            8.4.3.2. Financial performance
                            8.4.3.3. Product/Service benchmarking
                            8.4.3.4. Strategic initiatives
                        8.4.4. Takara Bio
                            8.4.4.1. Company overview
                            8.4.4.2. Financial performance
                            8.4.4.3. Product/Service benchmarking
                            8.4.4.4. Strategic initiatives
                        8.4.5. Promega Corporation
                            8.4.5.1. Company overview
                            8.4.5.2. Financial performance
                            8.4.5.3. Product/Service benchmarking
                            8.4.5.4. Strategic initiatives
                        8.4.6. Zymo Research
                            8.4.6.1. Company overview
                            8.4.6.2. Financial performance
                            8.4.6.3. Product/Service benchmarking
                            8.4.6.4. Strategic initiatives
                        8.4.7. MP BIOMEDICALS
                            8.4.7.1. Company overview
                            8.4.7.2. Financial performance
                            8.4.7.3. Product/Service benchmarking
                            8.4.7.4. Strategic initiatives
                        8.4.8. New England Biolabs
                            8.4.8.1. Company overview
                            8.4.8.2. Financial performance
                            8.4.8.3. Product/Service benchmarking
                            8.4.8.4. Strategic initiatives
                        8.4.9. MCLAB
                            8.4.9.1. Company overview
                            8.4.9.2. Financial performance
                            8.4.9.3. Product/Service benchmarking
                            8.4.9.4. Strategic initiatives
                        8.4.10. Applied Biological Materials, Inc.
                            8.4.10.1. Company overview
                            8.4.10.2. Financial performance
                            8.4.10.3. Product/Service benchmarking
                            8.4.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. plasmid purification market, by product & service, 2021 - 2033 (USD Million)
Table 3 U.S. plasmid purification market, by grade, 2021 - 2033 (USD Million)
Table 4 U.S. plasmid purification market, by application, 2021 - 2033 (USD Million)
Table 5 U.S. plasmid purification market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 U.S. Plasmid purification market: Market outlook
Fig. 5 U.S. Plasmid purification market: Segment outlook
Fig. 6 U.S. Plasmid purification market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 U.S. Plasmid purification market driver impact
Fig. 9 U.S. Plasmid purification market restraint impact
Fig. 10 U.S. Plasmid purification market: Product & service outlook and key takeaways
Fig. 11 U.S. Plasmid purification market: Product & service movement analysis
Fig. 12 Products market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 13 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 14 Kits & reagents market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 15 Services market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 16 U.S. Plasmid purification market: Grade outlook and key takeaways
Fig. 17 U.S. Plasmid purification market: Grade movement analysis
Fig. 18 Molecular-grade market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 19 Transfection grade market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 20 U.S. Plasmid purification market: Application outlook and key takeaways
Fig. 21 U.S. Plasmid purification market: Application movement analysis
Fig. 22 Cloning & protein expression market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 23 Transfection & gene editing market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 24 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 25 U.S. Plasmid purification market: End use outlook and key takeaways
Fig. 26 U.S. Plasmid purification market: End use movement analysis
Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 28 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)